"SMS Clinical Research is a privately owned and operated Research clinic located in Mesquite, Texas. Covering numerous areas of study, SMS Clinical Research provides opportunities for volunteers to participate in various clinical studies. Through these clinical studies, new medications and treatments can be found. Participants in clinical trials play an important role in the clinical research process, while also gaining access to medications otherwise unavailable to them. Volunteers are paid for their time and travel during any clinical trial they participate in."

During the past decade, SMS Clinical Research, LLC conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 6 clinical trials were completed, i.e. on average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 6 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SMS Clinical Research, LLC" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "BioNTech SE" with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored and "Abcentra" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SMS Clinical Research, LLC" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "HealthCore-NERI" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "SMS Clinical Research, LLC" are "COVID-19" (6 trials), "Covid19" (2 trials), "SARS-CoV-2 Infection" (2 trials), "Acute Respiratory Infection" (1 trials) and "Cardiometabolic Syndrome" (1 trials). Many other conditions were trialed in "SMS Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "SMS Clinical Research, LLC" are "Drug" (16 trials), "Biological" (6 trials), "Other" (5 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "BNT162b2" (2 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "BNT162b1" (1 trials). Other intervention names were less common.

The vast majority of trials in "SMS Clinical Research, LLC" are 23 trials for "All" genders.

Currently, there are NaN active trials in "SMS Clinical Research, LLC". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in SMS Clinical Research, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in SMS Clinical Research, LLC, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".